Business   

Wockhardt launches cetirizine in U.S.

CHENNAI: Wockhardt has announced the launch of Cetirizine tablets in the U.S. The company received the ANDA from the U.S. Food and Drug Administration (US FDA) for marketing the tablets containing 5mg and 10mg Cetirizine Hydrochloride, which is used for treating various forms of allergy. Cetirizine is the generic name for the brand Zyrtec, sold in the U.S. by Pfizer, the company informed the Bombay Stock Exchange.

Wockhardt is amongst the first companies to get the US FDA approval for this product as soon as the patent expired. Wockhardt USA Inc. has entered into a strategic marketing alliance with Leiner Health Products to market this product in the private label OTC markets," said the company’s Chairman Habil Khorakiwala.

Printer friendly page  
Send this article to Friends by E-Mail

Stories in this Section

FM non-committal on moderation in tax rates
Rising rupee pulls down export growth
New year starts on cautious note
I-T code will be released with discussion paper
Insiders may have to return ‘short swing profits’: SEBI draft
GAIL, RCF sign MoU
IT: domestic growth will balance global slowdown
Three States apply for petrochemical region
Wockhardt launches cetirizine in U.S.
Rupee ends steady
Exchange Rates
Bullion Rates
Import duty on wheat flour scrapped
Commission term extended
TRAI on broadband speed

Copyright © 2008, The Hindu. Republication or redissemination of the contents of this screen are expressly prohibited without the written consent of The Hindu